Feb 12, 2020
Global Bell's Palsy Incidence Assessment by Ethnicity & Geography, 2019-2029
Nov 07, 2019
Spinocerebellar Ataxia (SCA) Epidemiology Forecast to 2028: Assumptions and Rationale, Total Prevalent Population, Total Diagnosed Cases, Type-Specific Prevalence
Oct 23, 2019
Landmark Study Seeks Participants With VCFS-Related Psychosis to Help Create Biobank of Human Neural Tissue to Develop Innovative Treatments
Jul 09, 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Huntington's Disease
May 01, 2019
Positive clinical data at AAN 2019 reinforces Ionis' commitment to delivering life-changing medicines to patients with neurological diseases
Apr 30, 2019
TSC Global Awareness Day Scheduled for May 15
Apr 05, 2019
Dystrogen Therapeutics Announces That Gene Therapy Successfully Cuts Off Production of Neuron-Destroying Protein in Huntington's Disease
Mar 14, 2019
Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial Of Troriluzole
Nov 29, 2018
Tuberous Sclerosis Alliance Preclinical Consortium Announces New Staff and Company Members
Apr 30, 2018
Tuberous Sclerosis Complex Global Awareness Day Scheduled for May 15
Jan 12, 2018
Thyroid Cancer Markets Forecasts Report 2018-2028 - Focus on 21 Major Markets with Key Comorbid Conditions / Features Associated With the Disease
Jan 04, 2018
Tuberous Sclerosis Alliance Announces New Global Partnership in Hungary
Oct 27, 2017
Tuberous Sclerosis Alliance Submits "Voice of the Patient" Report To FDA
Oct 02, 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial